International Year of Chemistry, 2011

UNESCO - United Nations Educational, Scientific and Cultural Organization

Partners for the
International Year of Chemistry 2011

See all Activities

New Perspectives in Neurodegenerative Diseases and Cognition

Activity by Jacqui Colgate   |   added on Feb 01, 2011   |   United Kingdom Official_iyc_logo

Sponsor(s):

This conference covers recent advances in the discovery and development of new drugs for the treatment of chronic neurodegenerative disease.

New Perspectives in Neurodegenerative Diseases and Cognition

 

 

Pfizer Lecture Theatre, Department of Chemistry, University of Cambridge, UK
06 April 2011, 09.30 - 17.00
Organised by SCI's Fine Chemicals Group

Synopsis

This conference covers recent advances in the discovery and development of new drugs for the treatment of chronic neurodegenerative disease.

Chronic age related neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease represent a huge and increasing disease burden to society. By 2013 the incidence rate for Alzheimer’s disease is forecast to be 0.98% representing 7.4 million newly diagnosed patients per year.

By mid-century, estimates suggest that there will be more than 100 million patients worldwide. The drugs available for Alzheimer’s disease only treat the cognitive symptoms and the level of efficacy obtained is not regarded by some authorities as providing cost effective therapy. New treatments for disease progression and more effective symptomatic therapies are urgently required. The challenge involved in the discovery and development of novel drug targets for the treatment of neurodegenerative diseases is a major task for both the academic and pharmaceutical communities. This area represents the most important unmet medical need in the treatment of CNS disease.

The programme covers translational approaches to drug discovery and presents drug discovery strategies for symptomatic therapy and the reduction of disease progression.

Click here to read an article on 'New Perspectives in Neurodegenerative Diseases and Cognition'.

Posters

There will also be a poster session and interested delegates are strongly encouraged to submit their application for this early, as numbers will be limited. Please send a one-page abstract to conferences@soci.org by Friday 18 February 2011.

Who should attend?

This conference will be of interest to scientists engaged in the discovery and development of new treatments for chronic neurodegenerative diseases. In addition it will provide valuable insights to those working in the field of psychiatric diseases such as schizophrenia in which effective treatment of the cognitive burden of the disease is a major unmet need.

Programme

 

09.30

 

Registration and refreshments

10.10

 

Introduction and welcome

10.15

 

Strategies for cognitive translation from rodents to humans: implications for drug discovery
Tim Bussey, Cambridge University, UK
 

10.55

 

Neuroimaging from mouse to man – facilitating the drug discovery and development programme
Steve Williams, Kings College, London, UK

11.35  

Recent progress and remaining challenges in developing drugs to treat cognitive aspects and disease progression in Alzheimer's Disease
Michael O’Neill, Lilly, UK

12.15  

Lunch and posters

13.45  

New insights in the discovery of druggable H3R inverse agonists
Laurent Provins, UCB, Belgium

 

14.25  

Alpha7 positive modulators for the treatment of cognitive disorders
Andrew Lightfoot, GlaxoSmithKline, UK

15.05  

Refreshment break

15.45  

Potent and selective, orally active adenosine 2a receptor antagonists
Alexander Flohr, F.Hoffmann-La Roche AG, Switzerland
 

16.10  

Overview of progress of therapeutics in AD
Eric Karran, Janssen, Belgium
 

16.50  

Closing remarks
 

17.00  

Wine mixer

Organising Committee

Parminder Pooni, Takeda Cambridge Ltd
David Witty, ConvergencePharma
Stephen East, Evotec UK Ltd
 

Location

Pfizer Lecture Theatre, Department of Chemisty, University of Cambridge, UK
Please click here for a location map.
 

Delegate Fees

Please note fees include the 5% discount for making an online booking

Earlybird fees - before 04 March
GB£57.00 . . . . . . . . . SCI Member
GB£14.00. . . . . . . . . .SCI Student Member
GB£28.00 . . . . . . . . . SCI Subsidised Member
GB£76.00 . . . . . . . . . Non Member
 

Standard fees - after 04 March
GB£68.00 . . . . . . . . . SCI Member
GB£17.00 . . . . . . . . . SCI Student
GB£34.00 . . . . . . . . . SCI Subsidised Member
GB£91.00 . . . . . . ... . Non Member

 

For more information, please contact:

Conference Team
T: +44 (0)20 7598 1561
F: +44 (0)20 7235 7743
E: conferences@soci.org


 


Topic: chemistry education, conferences, seminars, networking, educational materials Audience: students, professional chemists, educators, professors, general public, industrial chemists, universities, research scientists, post graduate students, teachers, women chemists, educational institutions, decision makers, tertiary education
Want to submit your own activity or comment?

In order to do so you need to be part of the IYC network. Please or sign up now.

Join the IYC Network

Share |